Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study assessed safety, tolerability, and pharmacokinetics of multiple ascending doses of AZD8871 in healthy male Japanese subjects. The study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD8871 (AZD8871)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease - COPD | Phase 1 | Status: COMPLETED